Executive Management

David Chien
Chairman, President and CEO

David Chien has over 30 years of experience in the field of medical equipment, focusing primarily on corporate operations and sales and marketing. Chien is currently Chairman, President and CEO of OrbusNeich. He is devoted to the field of interventional cardiology and is the Vice Chairman of the Chien Foundation, a charitable organization with the vision of contributing to, and improving, the practice of cardiovascular medicine for physicians in the Asia-Pacific region. Apart from his interest in the medical equipment frontier, he also has 20 years of experience in real estate property investment, development and management in both Hong Kong and China. Until 2014 he held a position as Director of the Board of a listed Hong Kong company. He was responsible for organizing and managing the operations of the real estate property division of that company. Chien holds a BA in Business Administration from York University, Ontario, Canada.

Takeshi Ohba
President & Representative Director, OrbusNeich Japan

Takeshi Ohba has over 24 years of medical device experience and has served as the President of OrbusNeich Medical KK since 2002. Prior to joining, he worked at TUV Rheinland Japan as General Manager, at Jansen Pharmaceutical Japan (a Johnson & Johnson company) as a director in the sales promotion department and at Johnson & Johnson Medical K.K. (Cordis Cardiology) as a director of the marketing department. He graduated from Keio University, Tokyo and holds a Marketing degree from the Waseda University Business School.

Steve Rowland, PhD
Vice President Research and Development

Stephen Rowland joined OrbusNeich after a 14 year tenure at Cordis, where he was Vice President of Research and Development. Rowland was also Vice President and General Manager of Cordis Endovascular Systems, a separate business unit of Cordis focused on instrumentation to treat neurovascular diseases. He was responsible for all aspects of this start-up business including sales, marketing, development, strategic planning, and administration. His other experiences at Cordis included major contributions to advanced research and development across a variety of Cordis product initiatives. He is the inventor of nine issued U.S. patents, two published patent applications, and several other pending applications. Rowland holds a BS in Biology from West Virginia Wesleyan College and a PhD in Bio-engineering from the University of Utah.

Robert Cottone, Jr.
Vice President, Intellectual Property and Technologies

Robert Cottone co-founded Orbus Medical Technologies in 1996, the predecessor of OrbusNeich Medical. His prior experience includes working for Cordis Corporation (a Johnson & Johnson company) from 1988 until 1996. While at Cordis, Cottone managed the development, engineering, and manufacturing of several key product programs including diagnostic catheters, endomyocardial biopsy forceps, and peripheral vascular stents. In his current capacity as Vice President of Intellectual Property and Technologies at OrbusNeich, he oversees the global creation, construction, filing and prosecution of all OrbusNeich patents, copyrights and trademarks. He is instrumental in the concept, design and development for all stent and stent coating programs, and provides leadership and technical expertise to ensure OrbusNeich products meet clinical and market requirements. Cottone has a Bachelor of Science in Industrial Engineering from Florida International University. He is the named inventor of 31 issued U.S. patents and 56 U.S. patent applications, along with all of their corresponding international patent filings.

Jim Clossick
Vice President, Quality Assurance and Regulatory Affairs

Jim Clossick's background includes over 30 years of medical device experience. He specializes in international regulatory affairs, design control, process validation engineering, design of experiments, failure mode and effects analysis, customer requirements analysis, and quality functional deployment (QFD).Clossick provides leadership for seeking regulatory approvals for cardiovascular devices, including combination products. He holds two U.S. patents for device design. Clossick is a certified quality engineer, a certified Six Sigma Black Belt, and a certified QFD facilitator. In addition to his BS degree in Mechanical Engineering from the Missouri University of Science and Technology-Rolla, he has undertaken additional studies in Biomedical Engineering.